| Net cash provided by operating activities of continuing operations (Note 3) | |
| Capital expenditures | -107.53M |
| Origination of finance receivables held for investment | -1.99B |
| Collections on finance receivables held for investment | |
| Purchases of marketable securities | |
| Sales and redemptions of marketable securities | |
| Net cash provided by (used by) investing activities of continuing operations | |
| Proceeds from issuance of medium-term notes | 1.19B |
| Repayments of securitization debt | |
| Net increase in credit facilities and unsecured commercial paper | |
| Net change in restricted cash | 17.99M |
| Dividends | -127.8M |
| Purchase of common stock for treasury | -269.41M |
| Excess tax benefits from share-based payments | 331K |
| Issuance of common stock under employee stock option plans | |
| Net cash used by financing activities of continuing operations | |
| Effect of exchange rate changes on cash and cash equivalents of continuing operations | |
| Net decrease in cash and cash equivalents of continuing operations | |
| Cash flows from operating activities of discontinued operations | |
| Effect of exchange rate changes on cash and cash equivalents of discontinued operations | |
| Net cash used by discontinued operations, total | |
| Net decrease in cash and cash equivalents | 142.46M |
| Cash and cash equivalents - beginning of period | 722.21M |
| Cash and cash equivalents of discontinued operations - beginning of period | |
| Net decrease in cash and cash equivalents | 142.46M |
| Less: Cash and cash equivalents of discontinued operations - end of period | |
| Cash and cash equivalents - end of period | 864.67M |